Sleep Medicine
Volume 13, Issue 2 , Pages 133-138, February 2012

Efficacy and safety of doxepin 6mg in a four-week outpatient trial of elderly adults with chronic primary insomnia

  • Alan Lankford

      Affiliations

    • Sleep Disorders Center of Georgia, 5505 Peachtree Dunwoody Road, Suite 380, Atlanta, GA 30342, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 404 257 0080; fax: +1 404 257 0592.
    • ,
  • Roberta Rogowski

      Affiliations

    • Somaxon Pharmaceuticals, 6138 Tamilynn Street, San Diego, CA 92122, USA
    • ,
  • Beal Essink

      Affiliations

    • Oregon Center Clinical Investigation, 702 Church Street Northeast, Salem, OR 97301-2404, USA
    • ,
  • Elizabeth Ludington

      Affiliations

    • Somaxon Pharmaceuticals, 6138 Tamilynn Street, San Diego, CA 92122, USA
    • ,
  • H. Heith Durrence

      Affiliations

    • Somaxon Pharmaceuticals, 6138 Tamilynn Street, San Diego, CA 92122, USA
    • ,
  • Thomas Roth

      Affiliations

    • Henry Ford Sleep Disorders Center, 2799 West Grand Boulevard CFP-3, Detroit, MI 48202, USA

Received 7 April 2011; received in revised form 28 September 2011; accepted 29 September 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1389-9457(11)00341-8

doi:10.1016/j.sleep.2011.09.006

Sleep Medicine
Volume 13, Issue 2 , Pages 133-138, February 2012

Article Tools

* Image Usage & Resolution